At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 203 enrolled
Drug / intervention
IDP-118 Lotion +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
In Brief
A Phase 3 clinical trial evaluating IDP-118 Lotion and IDP-118 Vehicle Lotion for Plaque Psoriasis. Completed, enrolled 203 participants across 16 sites.
Detailed Summary
The objective of the study is to evaluate the safety and efficacy of a topical lotion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
CollaboratorsDow Pharmaceutical Sciences
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 2015
Enrollment StartAug 2015
Primary CompletionNov 2016
Study CompletionDec 2016
TodayJul 2026
First PostedJun 3, 2015
Enrollment StartAug 11, 2015
Primary CompletionNov 8, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.1 years ago
Interventions
IDP-118 Lotiondrug
Lotion
IDP-118 Vehicle Lotiondrug
Lotion